02.08.24 -- Evaluating Innovative Therapies And Making Sense Of New Data

Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies.

Experts discuss how to accelerate process analytics with fast nutrient screening at critical time points and the benefits of rapid media analysis in cell therapy development and viral vector production.

Cleaning surfaces and equipment in controlled environments have historically involved a variety of methods. Explore key takeaways from studies regarding the benefits of presaturated wipes.

The conventional approach to plasmid DNA design and construction is not amenable to fine-tuning the structure and properties of molecules. Consider this from-scratch method instead.

Since the first rAAV-based therapy was approved by the FDA, application of gene therapies utilizing rAAV vectors has exploded and active clinical programs are being fast-tracked for clinical approval.

Watch as speakers share a variety of challenges encountered when closing and automating ancillary processes and how closed automated platforms improved scalability and reproducibility.

Researchers looking for reliable ways to recapitulate physiological conditions are turning to spheroids and other 3D objects, seeking ways to mass-produce 3D models for various applications.

By exploring innovative approaches to scaling up animal cell growth in cutting-edge bioreactor systems, foodtech companies are poised to offer healthier, safer, more sustainable fish for consumers.

With continuously evolving gene therapy regulations, guidance, and limited time during development for testing, consider the four points this author makes when planning product-release testing.